Urban Training for COPD Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01897298 |
Recruitment Status :
Completed
First Posted : July 11, 2013
Last Update Posted : April 27, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Obstructive Pulmonary Disease (COPD) | Behavioral: Urban training | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 412 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Care Provider, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Effectiveness of an Intervention of Urban Training in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomised Controlled Trial |
Study Start Date : | July 2013 |
Actual Primary Completion Date : | February 2016 |
Actual Study Completion Date : | March 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Urban training Intervention
Patients will be advised to walk in the defined urban trails.
|
Behavioral: Urban training
Recommendation to walk a minimum of 5 days per week in urban walkable trails appropriate for the patient. |
No Intervention: Usual care
Patients will continue their usual care
|
- Change in physical activity [ Time Frame: Baseline and 12 months follow-up ]Change in physical activity between baseline and 12 months follow-up, as defined by average steps per day measured with an activity monitor
- COPD admissions to emergency-room or hospital [ Time Frame: 12 months follow-up ]
- Change in exercise capacity, as measured with 6-min walking distance [ Time Frame: Baseline and 12 months ]Change in exercise capacity between baseline and 12 months, as measured with 6-min walking distance
- Change in body weight and composition [ Time Frame: Baseline and 12 month ]Change in body weight and composition between baseline and 12m follow-up, as measured with bioimpedance
- Change in quality of life [ Time Frame: Baseline and 12-m ]Change in quality of life between baseline and 12-m follow-up, as measured with CAT and CCQ
- Change in anxiety and depression symptoms [ Time Frame: Baseline and 12 months ]Change in anxiety and depression symptoms between baseline and 12 months follw-up, as measured with the HAD scale
- Changes in cognitive status [ Time Frame: Baseline and 12months ]Changes between baseline and 12 months follow-up in cognitive status measured with the Phototest
- Changes in the Clinical PPAC [ Time Frame: Baseline and 12months ]Changes between baseline and 12 months follow-up in phsyical activity measured with the Clinical visit "PROactive Physical Activity in COPD" instrument

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 45 Years to 130 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age > 45 years
- COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
- clinical stability, defined as at least 4 weeks without antibiotics or oral corticosteroids.
Exclusion Criteria:
- living >6 months/year outside of the included municipalities,
- living to a distance higher than 500 meters to any of the urban trails used for the study,
- mental disability according to the Mini Mental State Examination in its validated Spanish version
- comorbidity that could interfere with study tests (e.g., lower limb amputation)
- severe psychiatric disease or severe comorbidity limiting survival at one year, according to medical history.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01897298
Spain | |
Hospital Germans Trias i Pujol | |
Badalona, Barcelona, Spain, 08916 | |
CAP Maresme | |
Mataró, Barcelona, Spain, 08303 | |
CAP Maria Bernades | |
Viladecans, Barcelona, Spain, 08840 | |
Hospital del Mar | |
Barcelona, Spain, 08003 | |
Hospital Clinic | |
Barcelona, Spain, 08036 |
Principal Investigator: | Judith Garcia-Aymerich, MD PhD | Centre for Research in Environmental Epidemiology (CREAL) |
Responsible Party: | Judith Garcia-Aymerich, Associate Research Professor, Barcelona Institute for Global Health |
ClinicalTrials.gov Identifier: | NCT01897298 |
Other Study ID Numbers: |
PI11/01283 147/2011 ( Other Grant/Funding Number: SEPAR ) |
First Posted: | July 11, 2013 Key Record Dates |
Last Update Posted: | April 27, 2018 |
Last Verified: | April 2018 |
chronic obstructive pulmonary disease (COPD) urban training physical activity active aging |
Lung Diseases Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases |
Chronic Disease Disease Attributes Pathologic Processes |